|Year : 2021 | Volume
| Issue : 6 | Page : 1561-1563
Assessment of effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes
Suman Bala1, Ranjna Kumari2
1 Department of Physiology, Government Medical College, Doda, Jammu and Kashmir, India
2 Department of Prosthodontics and Crown and Bridge, Desh Bhagat Dental College and Hospital, Mandi Gobindgarh, Punjab, India
|Date of Submission||30-Mar-2021|
|Date of Decision||02-May-2021|
|Date of Acceptance||06-May-2021|
|Date of Web Publication||10-Nov-2021|
Department of Prosthodontics and Crown and Bridge, Desh Bhagat Dental College and Hospital, Mandi Gobindgarh, Punjab
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Periodontitis is a chronic inflammatory disease of multifactorial etiology. The present study was conducted to assess the effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes. Materials and Methods: 80 type II diabetics patients of both genders were divided into Group I (periodontal and prosthodontic therapy) and Group II (Healthy). In control group, only oral hygiene instruction and mouth wash were prescribed. Results: Group I had 22 males and 18 females and Group II had 17 males and 23 females. The mean glycated hemoglobin level in Group I was 7.8% before and 6.7% after treatment and in Group II was 6.4% before and 6.2% after treatment. The difference was significant (P < 0.05). Conclusion: There was improvement in glycemic status in diabetic patients undergoing periodontal and prosthodontic therapy as compared to those not undergoing treatment.
Keywords: Diabetic, glycemic status, periodontal therapy, prosthodontic therapy
|How to cite this article:|
Bala S, Kumari R. Assessment of effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes. J Pharm Bioall Sci 2021;13, Suppl S2:1561-3
|How to cite this URL:|
Bala S, Kumari R. Assessment of effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes. J Pharm Bioall Sci [serial online] 2021 [cited 2022 Jun 26];13, Suppl S2:1561-3. Available from: https://www.jpbsonline.org/text.asp?2021/13/6/1561/330069
| Introduction|| |
Periodontitis is a chronic inflammatory disease of multifactorial etiology. The primary ideological factor remains pathogenic microorganisms whereby the destruction of periodontal apparatus results from the interplay between host immune microbial interactions. Moreover, microbiologic cause periodontitis is often influenced by systemic factors. Thus, many systemic disorders have an impact on periodontal health. Diabetes mellitus an autoimmune disorder is considered as a risk factor of periodontitis, which is often regarded as six complications of diabetes. Diabetes mellitus and periodontal disease are two common diseases that are in close relation to one another. Diabetes mellitus alters glucose tolerance or impairs metabolism of lipids and carbohydrates. Diabetes mellitus is often preceded by low-grade inflammatory response. This indicates that diabetes and periodontitis may be associated through the dysregulated inflammatory immune response. Diabetes mellitus patients usually present with advanced periodontal destruction, having deficit or impaired glucose tolerance depending on the type of diabetes.
Gingival crevicular fluid is a serum transudate originating from the gingival plexus of blood vessels. It has been shown that elevated serum levels of inflammatory mediators and cytokines such as tumor necrosis factor-alpha in diabetic patients correlated with increased levels of these mediators and cytokines in gingival crevicular fluid. Systemic infection of Gram-negative organisms such as Porphyromonas gingivalis, Tannerella forsythensis, and Prevotella intermedia, or their products may promote an elevated inflammatory state and increased levels of serum inflammatory markers. The present study was conducted to assess the effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes.
| Materials and Methods|| |
The present study comprised of 80 type II diabetics of both genders. All were taken into study after obtaining their written consent.
Data such as name and age were recorded. Grouping of participants in Group I (periodontal and prosthodontic therapy) and Group II (no therapy) was done. The level of glycated hemoglobin was assessed. Full mouth scaling, subgingival curettage, extraction, and flap operation performed under local anesthesia. Prosthodontic therapy consisted of implant prosthodontics, single and bridge restorations, occlusal adjustment, and removable partial denture was done. Patients in the Group I received at least one of these therapies. In control group, only oral hygiene instruction and mouth wash was prescribed. Results were analyzed statistically. P <0.05 was considered significant.
| Results|| |
[Table 1] and [Graph 1] show that Group I had 22 males and 18 females and Group II had 17 males and 23 females.
[Table 2] and [Graph 2] show that mean glycated hemoglobin (HbA1C) level in Group I was 7.8% before and 6.7% after treatment and in Group II was 6.4% before and 6.2% after treatment. The difference was significant (P < 0.05).
|Table 2: Assessment of glycated hemoglobin level before and after treatment in both groups|
Click here to view
| Discussion|| |
Diabetes is characterized by an increased susceptibility to infection, poor wound healing, and increased morbidity and mortality. Oral cavity provides a continuous source of infectious agents, and its condition often reflects the progression of systemic pathologies. Diabetes is also recognized as an important risk factor for more severe and progressive periodontitis infection or lesions resulting in the destruction of tissues and supporting bone that forms the attachment around the tooth. It is considered as a manifestation of a persistent chronic low-grade inflammation. Periodontal disease is a chronic inflammatory condition that causes an imbalance in anabolic and catabolic processes, ultimately resulting in resorption of alveolar bone or tooth-supporting tissues. The present study was conducted to assess the effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes.
In the present study, Group I had 22 males and 18 females and Group II had 17 males and 23 females. Kim et al. in their study among the 70 patients, 35 patients receive periodontal and prosthodontic therapy, while the other 35 patients did not receive such therapy. The HbA1c levels were compared before and after periodontal and prosthodontic therapy. Comparisons between groups and within groups were performed. The HbA1c levels in the group who have received periodontal and prosthodontic therapy decreased from 7.2 to 6.7 (P = .001). The HbA1c levels in the control group decreased from 7.2 to 7.1 (P = .580). The difference in changes between the two patient groups was statistically significant (P = .011).
We found that mean HbA1C level in Group I was 7.8% before and 6.7% after treatment and in Group II was 6.4% before and 6.2% after treatment. Polak and Shapira suggested a biological pathway that the elevated pro-inflammatory factors in the gingiva of patients with poorly controlled serum glucose may aggravate periodontitis.
Munjal et al. evaluated and investigated changes in HbA1c levels before and after nonsurgical periodontal therapy in type-2 diabetes mellitus patients with generalized periodontitis. The selected participants were randomly allocated to two groups. Group I: control group: participants who received only scaling and root planing. Group II: test group: participants received antibiotic coverage with nonsurgical periodontal therapy (scaling and root planning). Clinical parameters included plaque index, gingival index, PRO MIG pocket depth, and clinical attachment level. In addition, the metabolic parameters were recorded at the same time intervals, which included fasting blood sugar, random blood sugar, and HbA1c levels. HbA1c more significantly reduced by test group compared to the other group. There is definitely a positive effect of nonsurgical on HbA1c levels in type 2 diabetes mellitus. These point levels significantly reduced after conventional nonsurgical periodontal therapy.
Moeintaghavi et al. noted a significant reduction of HbA1c level (0.74%) in the treatment group after 3 months. According to previous studies, the magnitude of the reduction in HbA1c ranged from 0.27% to 0.48%, 3–4 months after periodontal treatment. Despite periodontal treatment seeming to ameliorate metabolic control, evidence was not sufficient to significant associate periodontal treatment and metabolic control in patients with diabetes. According to a consensus report, there is a lack of data to manifest that this effect is maintained over 6 months following periodontal treatment.
| Conclusion|| |
Authors found that there was improvement in glycemic status in diabetic patients undergoing periodontal and prosthodontic therapy as compared to those not undergoing treatment.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Salvi GE, Yalda B, Collins JG, Jones BH, Smith FW, Arnold RR, et al.
Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-35.
Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the relation between periodontal health status and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 2000;151:273-82.
Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 2004;123:87-92.
Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-7.
Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71:1528-34.
Mealey BL, Oates TW, American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-303.
Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol 2001;28:306-10.
Li Q, Hao S, Fang J, Xie J, Kong XH, Yang JX. Effect of non-surgical periodontal treatment on glycemic control of patients with diabetes: A meta-analysis of randomized controlled trials. Trials 2015;16:291.
Teshome A, Yitayeh A. The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: Systematic review and meta-analysis. BMC Oral Health 2016;17:31.
Mauri-Obradors E, Merlos A, Estrugo-Devesa A, Jané-Salas E, López-López J, Viñas M. Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial. J Clin Periodontol 2018;45:345-53.
Kim HK, Kim YG, Cho JH, Lee SK, Lee JM. The effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes. J Adv Prosthodont 2019;11:247-52.
Polak D, Shapira L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2018;45:150-66.
Munjal A, Jain Y, Kote S, Krishnan V, Fahim R, Metha SS, et al
. A study on the change in HbA1c levels before and after non-surgical periodontal therapy in type-2 diabetes mellitus in generalized periodontitis. J Family Med Prim Care 2019;8:1326-9.
] [Full text]
Moeintaghavi A, Arab HR, Bozorgnia Y, Kianoush K, Alizadeh M. Non-surgical periodontal therapy affects metabolic control in diabetics: A randomized controlled clinical trial. Aust Dent J 2012;57:31-7.
Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al.
The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72:774-8.
[Table 1], [Table 2]